Jazz Pharmaceuticals plc Overview
Jazz Pharmaceuticals plc Target Price
Analysts' 12-month price predictions for JAZZ.
Share Price
$110.31
Average Target Price
$188.00
70.4% upside
70.4% upside1 analysts in the last 4 months
High: $188 | Low: $188
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-20 | Piper SandlerDavid Amsellem | $188 | 70.4% upside |  |
| 2022-12-09 | Goldman Sachs | $190 | 72.2% upside | |
| 2022-11-10 | Goldman Sachs | $192 | 74.1% upside | |
| 2022-11-10 | RBC Capital | $207 | 87.7% upside | |
| 2022-06-20 | Piper SandlerDavid Amsellem | $193 | 75% upside | |
| 2022-06-13 | UBSAshwani Verma | $194 | 75.9% upside | |
| 2022-03-03 | NeedhamAmi Fadia | $215 | 94.9% upside | |
| 2022-01-20 | Truist FinancialGreg Fraser | $200 | 81.3% upside | |
| 2022-01-14 | Stifel NicolausAnnabel Samimy | $210 | 90.4% upside | |
| 2022-01-03 | BernsteinAaron Gal | $175 | 58.6% upside | |
| 2021-11-10 | Bank of America SecuritiesJason Gerberry | $193 | 75% upside | |
| 2021-10-06 | Cantor FitzgeraldBrandon Folkes | $210 | 90.4% upside | |
| 2021-10-05 | CitigroupNavann Ty | $200 | 81.3% upside | |
| 2021-06-22 | BarclaysBalaji Prasad | $250 | 126.6% upside | |
| 2021-06-18 | UBSEsther Rajavelu | $234 | 112.1% upside | |
| 2021-05-10 | Cowen & Co.Ken Cacciatore | $200 | 81.3% upside | |